ask="7.00"
ask_size="100"
average_daily_volume="343515"
bid="N/A"
bid_size="N/A"
book_value="3.69"
change="-0.20"
change_from_200_day_moving_average="-4.04"
change_from_50_day_moving_average="-3.04"
change_from_52_week_high="-8.15"
change_From_52_week_low="2.57"
change_in_percent="-3.01%"
close="6.45"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.17"
ebitda="-38.95M"
eps_estimate_current_year="-2.14"
eps_estimate_next_quarter="-0.52"
eps_estimate_next_year="-2.05"
ex_dividend_date="N/A"
float_shares="16063000"
high="6.65"
high_52_weeks="14.60"
last_trade_date="2/23/2017"
last_trade_price="6.45"
last_trade_size="4137"
last_trade_time="4:00pm"
low="6.35"
low_52_weeks="3.88"
market_capitalization="115.11M"
moving_average_200_day="10.49"
moving_average_50_day="9.49"
name="Stemline Therapeutics
Inc."
notes="N/A"
one_year_target_price="25.50"
open="6.65"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-38.49%"
percent_change_from_50_day_moving_average="-32.03%"
percent_change_from_52_week_high="-55.82%"
percent_change_from_52_week_low="+66.24%"
previous_close="6.65"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.80"
price_per_sales="125.24"
revenue="947604.00"
shares_outstanding="17846000"
short_ratio="1.96"
stock_exchange="NCM"
symbol="STML"
volume="281672"
weeks_range_52="3.88 - 14.60"
